ENGI-006

N/A

Report date: 2024/06/24 16:55:57

Base Information

Drug NameENGI-006
Drug Alias NameENGI-006
ClassificationBiologics
Mechanisms of ActionImmunologic cytotoxicityT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEngimmune Therapeutics AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A